168 related articles for article (PubMed ID: 37133630)
21. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
22. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
[TBL] [Abstract][Full Text] [Related]
23. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
24. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
Schaller AKCS; Peterson A; Bäckryd E
Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses.
Raza A; Karimyan N; Watters A; Emperumal CP; Al-Eryani K; Enciso R
Support Care Cancer; 2022 Nov; 30(11):8689-8703. PubMed ID: 35680672
[TBL] [Abstract][Full Text] [Related]
27. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
28. Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.
Nugent M; Bryant V; Butcher C; Fisher H; Gill S; Goranova R; Hiu S; Lindley L; O'Hara J; Oluboyede Y; Patterson J; Rapley T; Robinson T; Rousseau N; Ryan V; Shanmugasundaram R; Sharp L; Smith Whelan R; Stocken DD; Ternent L; Wilson J; Walker J
Health Technol Assess; 2022 Dec; 26(46):1-172. PubMed ID: 36484364
[TBL] [Abstract][Full Text] [Related]
29. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
30. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
31. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
[TBL] [Abstract][Full Text] [Related]
32. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
[TBL] [Abstract][Full Text] [Related]
35. Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy.
Ebert N; Kensche A; Löck S; Hadiwikarta WW; Hänsch A; Dörr W; Krause M; Hannig C; Baumann M
Strahlenther Onkol; 2021 Jan; 197(1):63-73. PubMed ID: 32970162
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis.
Akagi S; Fujiwara T; Nishida M; Okuda A; Nagao Y; Okuda T; Tokuda H; Takayanagi K
J Pharm Health Care Sci; 2019; 5():16. PubMed ID: 31367460
[TBL] [Abstract][Full Text] [Related]
38. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
39. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
Li E; Trovato JA
Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
[TBL] [Abstract][Full Text] [Related]
40. Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection.
Yamaguchi T; Makiguchi T; Nakamura H; Yamatsu Y; Hirai Y; Shoda K; Suzuki K; Kim M; Kurozumi S; Motegi SI; Shirabe K; Yokoo S
Int J Oral Maxillofac Surg; 2021 Sep; 50(9):1195-1202. PubMed ID: 33414037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]